Download PDF
Geburtshilfe Frauenheilkd 2006; 66(4): R61-R88
DOI: 10.1055/s-2006-924113
GebFra-Refresher

Georg Thieme Verlag KG Stuttgart · New York

Endometriose

S. P. Renner1 , P. Oppelt1 , H. Binder1 , M. W. Beckmann1
  • 1Frauenklinik Universität Erlangen, Erlangen
Further Information

Publication History

Publication Date:
11 May 2006 (online)

Also available at
    Permissions and Reprints

Obwohl die Endometriose erstmals bereits im späten 17. Jahrhundert beschrieben wurde, wird diese Erkrankung bis heute aufgrund des leider weitgehend fehlenden wissenschaftlichen und klinischen Interesses häufig als „forgotten disease“ bezeichnet [[1]]. Selbst in aktuellen Abhandlungen über Erkrankungen des Menschen (Encyclopedia of Medical History, 1985 und The Cambridge World History of Human Disease, 1993) sucht man vergebens nach einem Hinweis auf Endometriose [[2], [3]]. Angesichts der hohen Prävalenz der Erkrankung erscheint dies verwunderlich. Ein Grund liegt sicherlich in der weitgehend unverstandenen Ätiologie sowie der schwierigen Diagnostik und Therapie dieser rätselhaften Erkrankung. Dieser Refresher soll eine kurze, sicherlich nicht allumfassende Darstellung der Erkrankung geben, um sie weiter in den Mittelpunkt des klinischen und basiswissenschaftlichen Interesses zu rücken. Dies scheint aufgrund des hohen Leidensdruckes der Patientinnen sowie nicht zuletzt auch der hohen volkswirtschaftlichen Bedeutung der Endometriose durch Arbeitsausfall und medizinischen Aufwand mehr als überfällig zu sein.

Literatur

  • 1 Knapp V J. How old is endometriosis? Late 17th- and 18th-century European descriptions of the disease.  Fertil Steril. 1999;  72 10-14
    CrossrefPubMedGoogle Scholar
  • 2 Kiple K. The Cambridge World History of Human Disease. Cambridge; Cambridge University Press 1993
    Google Scholar
  • 3 McGrew R. Encyclopedia of medical history. New York; McGraw-Hill 1985
    Google Scholar
  • 4 Mahmood T A, Templeton A. Prevalence and genesis of endometriosis.  Hum Reprod. 1991;  6 544-549
    CrossrefPubMedGoogle Scholar
  • 5 Moen M H, Schei B. Epidemiology of endometriosis in a Norwegian county.  Acta Obstet Gynecol Scand. 1997;  76 559-562
    CrossrefPubMedGoogle Scholar
  • 6 Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors.  Best Pract Res Clin Obstet Gynaecol. 2004;  18 177-200
    CrossrefPubMedGoogle Scholar
  • 7 Witz C A, Burns W N. Endometriosis and infertility: is there a cause and effect relationship?.  Gynecol Obstet Invest. 2002;  53 (Suppl 1) 2-11
    CrossrefPubMedGoogle Scholar
  • 8 Simpson J L, Elias S, Malinak L R, Buttram Jr V C. Heritable aspects of endometriosis. I. Genetic studies.  Am J Obstet Gynecol. 1980;  137 327-331
    CrossrefPubMedGoogle Scholar
  • 9 Meyer R. Über den Stand der Frage der Adenomyositis, Adenomyome im Allgemeinen und insbesondere über Adenomyositis seroepithelialis und Adenomyometritis sarcomatosa.  Zentralbl Gynakol. 1919;  36 745-750
    PubMedGoogle Scholar
  • 10 Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity.  Am J Obst Gynecol. 1927;  14 442-469
    PubMedGoogle Scholar
  • 11 D'Hooghe T M, Bambra C S, Raeymaekers B M, De Jonge I, Lauweryns J M, Koninckx P R. Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis).  Am J Obstet Gynecol. 1995;  173 125-134
    CrossrefPubMedGoogle Scholar
  • 12 Sharpe-Timms K L. Using rats as a research model for the study of endometriosis.  Ann N Y Acad Sci. 2002;  955 318-327 340-312 396-406
    CrossrefPubMedGoogle Scholar
  • 13 American_Society_for_Reproductive_Medicine . Revised American Society for Reproductive Medicine classification of endometriosis: 1996.  Fertil Steril. 1997;  67 817-821
    CrossrefPubMedGoogle Scholar
  • 14 Tuttlies F, Keckstein J, Ulrich U. et al . [ENZIAN‐score, a classification of deep infiltrating endometriosis].  Zentralbl Gynakol. 2005;  127 275-281
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Schweppe K W. [Endometriosis - a disease that has no lobby].  Zentralbl Gynakol. 2003;  125 233
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Renner S P, Strick R, Oppelt P. et al . Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis.  Reproduction. 2006;  131 153-161
    CrossrefPubMedGoogle Scholar
  • 17 Sallam H, Garcia-Velasco J, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis.  Cochrane Database Syst Rev. 2006;  CD004635
    PubMedGoogle Scholar
  • 18 Alborzi S, Momtahan M, Parsanezhad M E, Dehbashi S, Zolghadri J, Alborzi S. A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas.  Fertil Steril. 2004;  82 1633-1637
    CrossrefPubMedGoogle Scholar
  • 19 Saleh A, Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration.  Fertil Steril. 1999;  72 322-324
    CrossrefPubMedGoogle Scholar
  • 20 Hart R, Hickey M, Maouris P, Buckett W, Garry R. Excisional surgery versus ablative surgery for ovarian endometriomata.  The Cochrane Database of Systematic Reviews. 2005;  3 CD004992 DOI: 10.1002/14651858.CD004992.pub2
    PubMedGoogle Scholar
  • 21 Mueller A, Thiel F, Binder H. et al . GebFra-Refresher Myome - Teil 1.  Geburtsh Frauenheilk. 2004;  64 R229-R244
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Mueller A, Oppelt P, Ackermann S, Binder H, Beckmann M W. The Hohl instrument for optimizing total laparoscopic hysterectomy procedures.  J Minim Invasive Gynecol. 2005;  12 432-435
    CrossrefPubMedGoogle Scholar
  • 23 Mueller A, Thiel F, Binder H. et al . GebFra-Refresher Myome - Teil 2.  Geburtsh Frauenheilk. 2004;  64 R245-R260
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Schweppe K W. [Guidelines for the use of GnRH‐analogues in the treatment of endometriosis].  Zentralbl Gynakol. 2005;  127 308-313
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Zupi E, Marconi D, Sbracia M. et al . Add-back therapy in the treatment of endometriosis-associated pain.  Fertil Steril. 2004;  82 1303-1308
    CrossrefPubMedGoogle Scholar
  • 26 Busacca M, Somigliana E, Bianchi S. et al . Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III - IV: a randomized controlled trial.  Hum Reprod. 2001;  16 2399-2402
    CrossrefPubMedGoogle Scholar
  • 27 Hornstein M D, Yuzpe A A, Burry K A, Heinrichs L R, Buttram Jr V L, Orwoll E S. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain.  Fertil Steril. 1995;  63 955-962
    CrossrefPubMedGoogle Scholar
  • 28 Vercellini P, Crosignani P G, Fadini R, Radici E, Belloni C, Sismondi P. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis.  Br J Obstet Gynaecol. 1999;  106 672-677
    CrossrefPubMedGoogle Scholar
  • 29 Hornstein M D, Hemmings R, Yuzpe A A, Heinrichs W L. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.  Fertil Steril. 1997;  68 860-864
    CrossrefPubMedGoogle Scholar
  • 30 Hornstein M D, Surrey E S, Weisberg G W, Casino L A. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.  Obstet Gynecol. 1998;  91 16-24
    CrossrefPubMedGoogle Scholar
  • 31 Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis.  Cochrane Database Syst Rev. 2000;  2 CD001019
    PubMedGoogle Scholar
  • 32 Fedele L, Berlanda N. Emerging drugs for endometriosis.  Expert Opin Emerg Drugs. 2004;  9 167-177
    CrossrefPubMedGoogle Scholar
  • 33 Goretzlehner G. [Menstrual bleeding - must that be? Extended use of oral hormonal contraceptives].  Zentralbl Gynakol. 2005;  127 302-307
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Anderson F D, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive.  Contraception. 2003;  68 89-96
    CrossrefPubMedGoogle Scholar
  • 35 Mahutte N G, Arici A. Medical management of endometriosis-associated pain.  Obstet Gynecol Clin North Am. 2003;  30 133-150
    CrossrefPubMedGoogle Scholar
  • 36 Prentice A, Deary A J, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis.  Cochrane Database Syst Rev. 2000;  2 CD002122
    PubMedGoogle Scholar
  • 37 Regidor P A, Regidor M, Schmidt M. et al . Prospective randomized study comparing the GnRH‐agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.  Gynecol Endocrinol. 2001;  15 202-209
    CrossrefPubMedGoogle Scholar
  • 38 Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani P G. Progestogens for endometriosis: forward to the past.  Hum Reprod Update. 2003;  9 387-396
    CrossrefPubMedGoogle Scholar
  • 39 Vercellini P, Vigano P, Somigliana E. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.  Curr Opin Obstet Gynecol. 2005;  17 359-365
    CrossrefPubMedGoogle Scholar
  • 40 Petta C A, Ferriani R A, Abrao M S. et al . Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.  Hum Reprod. 2005;  20 1993-1998
    CrossrefPubMedGoogle Scholar
  • 41 Allen C, Hopewell S, Prentice A, Allen C. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis.  Cochrane Database Syst Rev. 2005;  4 CD004753
    PubMedGoogle Scholar
  • 42 Sagsveen M, Farmer J E, Prentice A, Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.  Cochrane Database Syst Rev. 2003;  CD001297
    PubMedGoogle Scholar
  • 43 Attar E, Bulun S E. Aromatase and other steroidogenic genes in endometriosis: translational aspects.  Hum Reprod Update. 2005;  12 49-56
    CrossrefPubMedGoogle Scholar
  • 44 Ebert A D, Bartley J, David M. Aromatase inhibitors and cyclooxygenase-2 (COX‐2) inhibitors in endometriosis: new questions - old answers?.  Eur J Obstet Gynecol Reprod Biol. 2005;  122 144-150
    CrossrefPubMedGoogle Scholar
  • 45 Pritts E A, Taylor R N. An evidence-based evaluation of endometriosis-associated infertility.  Endocrinol Metab Clin North Am. 2003;  32 653-667
    CrossrefPubMedGoogle Scholar
  • 46 Omland A K, Tanbo T, Dale P O, Abyholm T. Artificial insemination by husband in unexplained infertility compared with infertility associated with peritoneal endometriosis.  Hum Reprod. 1998;  13 2602-2605
    CrossrefPubMedGoogle Scholar
  • 47 Wu M Y, Ho H N. The role of cytokines in endometriosis.  Am J Reprod Immunol. 2003;  49 285-296
    CrossrefPubMedGoogle Scholar
  • 48 Kissler S, Hamscho N, Zangos S. et al . Diminished pregnancy rates in endometriosis due to impaired uterotubal transport assessed by hysterosalpingoscintigraphy.  Bjog. 2005;  112 1391-1396
    PubMedGoogle Scholar
  • 49 Garrido N, Navarro J, Garcia-Velasco J, Remoh J, Pellice A, Simon C. The endometrium versus embryonic quality in endometriosis-related infertility.  Hum Reprod Update. 2002;  8 95-103
    CrossrefPubMedGoogle Scholar
  • 50 Garcia-Velasco J A, Mahutte N G, Corona J. et al . Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study.  Fertil Steril. 2004;  81 1194-1197
    CrossrefPubMedGoogle Scholar
  • 51 Simon C, Gutierrez A, Vidal A. et al . Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation.  Hum Reprod. 1994;  9 725-729
    PubMedGoogle Scholar
  • 52 Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization.  Fertil Steril. 2002;  77 1148-1155
    CrossrefPubMedGoogle Scholar
  • 53 Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery.  The Cochrane Database of Systematic Reviews. 2000;  2 CD003678 DOI: 10.1002/14651858.CD003678
    PubMedGoogle Scholar
  • 54 Hughes E, Fedorkow D, Collins J, Vandekerckhove P. Ovulation suppression for endometriosis.  The Cochrane Database of Systematic Reviews. 2003;  3 CD000155 DOI: 10.1002/14651858.CD000155
    PubMedGoogle Scholar
  • 55 Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis.  Fertil Steril. 2002;  78 757-762
    CrossrefPubMedGoogle Scholar
  • 56 Hughes E G, Fedorkow D M, Collins J A. A quantitative overview of controlled trials in endometriosis-associated infertility.  Fertil Steril. 1993;  59 963-970
    PubMedGoogle Scholar
  • 57 Jacobson T, Barlow D, Koninckx P, Olive D, Farquhar C. Laparoscopic surgery for subfertility associated with endometriosis.  The Cochrane Database of Systematic Reviews. 2002;  4 CD001398 DOI: 10.1002/14651858.CD001398
    PubMedGoogle Scholar
  • 58 Strowitzki T. [Infertility treatment and endometriosis - risk and benefit of assisted reproductive techniques].  Zentralbl Gynakol. 2005;  127 314-319
    Article in Thieme ConnectPubMedGoogle Scholar
  • 59 Deaton J L, Gibson M, Blackmer K M, Nakajima S T, Badger G J, Brumsted J R. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis.  Fertil Steril. 1990;  54 1083-1088
    PubMedGoogle Scholar
  • 60 Tummon I S, Asher L J, Martin J S, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis.  Fertil Steril. 1997;  68 8-12
    CrossrefPubMedGoogle Scholar
  • 61 Jansen R P. Relative infertility: modeling clinical paradoxes.  Fertil Steril. 1993;  59 1041-1045
    PubMedGoogle Scholar
  • 62 Somigliana E, Vercellini P, Vigano P, Ragni G, Giorgio Crosignani P. Should endometriomas be treated before IVF-ICSI cycles?.  Hum Reprod Update 2005;. 2006;  12 57-64
    PubMedGoogle Scholar

Dr. Stefan P. Renner

Frauenklinik Universität Erlangen

Universitätsstraße 21 - 23

91054 Erlangen

Email: Stefan.Renner@gyn.imed.uni-erlangen.de

      >